In contrast, the number of apoptotic cells significantly increased in both EGFR-high and -low tumor tissues after dasatinib treatment and more so after combination therapy with dasatinib plus cetuximab, as assessed by TUNEL staining (Fig. 7c and Fig. S8B). This evidence concerns the gene EGFR and neoplasm.